Viewing Study NCT00270361


Ignite Creation Date: 2025-12-24 @ 12:17 PM
Ignite Modification Date: 2026-02-25 @ 12:56 AM
Study NCT ID: NCT00270361
Status: COMPLETED
Last Update Posted: 2011-07-26
First Post: 2005-12-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: FUSION I Assesses Safety and Tolerability of Two Doses of NATRECOR (Nesiritide) Administered to Patients With Worsening Congestive (Decompensated) Heart Failure Who Are Concurrently Receiving Their Usual Cardiac Medications and Are at High Risk for Hospitalization.
Sponsor: Scios, Inc.
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Heart Failure, Congestive View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Heart Failure View
None Renal Dysfunction View
None Cardiomyopathy View
None Heart Decompensation View
None Dyspnea Paroxsymal View
None Outpatient Therapy. View